Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Differential ErbB1 signaling in squamous cell versus basal cell carcinoma of the skin.

Differential ErbB1 signaling in squamous cell versus basal cell carcinoma of the skin. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Differential ErbB1 signaling in squamous cell versus basal cell carcinoma of the skin. Abstract Text:

    laure Laure ,sanjay kansraSanjay Kansra,stefan w stollStefan W Stoll,yong liYong Li,johann e gudjonssonJohann E Gudjonsson,yuan shaoYuan Shao,lowell e michaelLowell E Michael,gary j fisherGary J Fisher,timothy m johnsonTimothy M Johnson,james t elderJames T Elder,

    In this study, we examined ErbB1 signaling in human basal and squamous cell carcinomas (BCC and SCC) of the skin in vivo. We used enzyme-linked immunosorbent assay, laser capture microdissection-coupled real-time reverse transcriptase-polymerase chain reaction, and immunohistochemistry to assess expression and activation levels of ErbB1 protein, ligands, and potential downstream effectors, in BCC and SCC tumors, stroma, and adjacent epidermis. Although total ErbB1 protein and mRNA were similar in cancerous and normal skin, we found that ErbB1 activation (phospho-Tyr(1068)) was greater in bulk SCC versus BCC or normal skin. In addition, three ErbB1 ligand transcripts (amphiregulin, heparin-binding epidermal growth factor-like growth factor, and transforming growth factor-alpha) were up-regulated in tumor cells of SCC but not BCC. Expression of these ligands was also increased in asymptomatic epidermis adjacent to both SCC and BCC, relative to normal skin. Interestingly, betacellulin transcript levels were inversely regulated compared with the other ligands. Consistently, downstream ErbB1 effectors (Erk1/2 and Akt) were activated in tumor cells of SCC but not of BCC and in adjacent epidermis of both BCC and SCC. These results demonstrate that ErbB1 signaling is hyperactive in tumor cells of SCC but not of BCC and in nearby asymptomatic epidermis of both tumor types. Our results suggest that targeting ErbB1 signaling might be of benefit in the treatment of SCC.

    Differential ErbB1 signaling in squamous cell versus basal cell carcinoma of the skin. Publishing Authors By Initials

    l L ,s kansraS Kansra,sw stollSW Stoll,y liY Li,je gudjonssonJE Gudjonsson,y shaoY Shao,le michaelLE Michael,gj fisherGJ Fisher,tm johnsonTM Johnson,jt elderJT Elder,

    For similar peptides: intercellular signaling peptides and proteins: transforming growth factors: transforming growth factor alpha research abstracts see: peptides: intercellular signaling peptides and proteins: transforming growth factors: transforming growth factor alpha research

    PUBMED ID PMID:

    MEDLINE DATE:

    Differential ErbB1 signaling in squamous cell versus basal cell carcinoma of the skin. Journal Published:

    PUBLICATION TYPE: Research Support, U.S. Gov't,

    Journal: The American journal of pathology

    VOLUME: 170

    Page Numbers: 2089-99

    Journal Abbreviation: Am. J. Pathol.

    ISSN: 0002-9440

    DAY: 3

    MONTH: Jun

    YEAR: 2007

    Differential ErbB1 signaling in squamous cell versus basal cell carcinoma of the skin. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 370502

    Differential ErbB1 signaling in squamous cell versus basal cell carcinoma of the skin. Keywords Mesh Terms:

    KEYWORDS: Transforming Growth Factor alpha

    MESH TERMS: metabolism

    Chemical & Substance for Abstract: Differential ErbB1 signaling in squamous cell versus basal cell carcinoma of the skin. Information

    Substance Name: Proto-Oncogene Proteins c-akt

    Registry Number: EC 2.7.1.37

    Grant and Affiliation Information for Differential ErbB1 signaling in squamous cell versus basal cell carcinoma of the skin.

    AFFILIATION: Department of Dermatology, University of Michigan Medical Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109-0932, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NIAMS

    GRANT: T32 AR 07197

    ACRONYM: AR

    MEDLINETA: Am J Pathol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Differential ErbB1 signaling in squamous cell versus basal cell carcinoma of the skin Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News